Jennifer Cote
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jennifer Cote
Jennifer Cote was last confirmed as CFO at Harvard Bioscience Inc (HBIO) in a filing dated April 21, 2025. Harvard Bioscience Inc reported in an 8-K filed June 20, 2023 that Jennifer Cote was appointed Chief Financial Officer and Treasurer, effective June 19, 2023. The proxy statement of Harvard Bioscience Inc reports total compensation of $123,006 for Jennifer Cote in fiscal 2025, including a base salary of $118,846. Disclosed compensation is on record for 3 fiscal years. Jennifer Cote has spoken on 9 earnings calls across 1 company, most recently for Harvard Bioscience Inc on March 19, 2025.
“On June 20, 2023, Harvard Bioscience, Inc. (the “Company”) issued a press release announcing the appointment of Jennifer Cote as the Company’s Chief Financial Officer and Treasurer effective as of June 19, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2025-04-21
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Harvard Bioscience Inc (HBIO) | Former Chief Financial Officer and Treasurer | $118,846 | $123,006 |
| 2024 | Harvard Bioscience Inc (HBIO) | Chief Financial Officer and Treasurer | $293,654 | $602,601 |
| 2023 | Harvard Bioscience Inc (HBIO) | Chief Financial Officer and Treasurer | $285,789 | $571,272 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.